Global Cancer Biopsy Market Overview:
Global Cancer Biopsy Market is expected to grow at a significant rate during the forecast period 2026-2035, with 2025 as the base year.
Global Cancer Biopsy Market Report 2026 comes with the extensive industry analysis by Introspective Market Research with development components, patterns, flows and sizes. The report also calculates present and past market values to forecast potential market management through the forecast period between 2026-2035, with base year as 2025. This research study of Cancer Biopsy involved the extensive usage of both primary and secondary data sources. This includes the study of various parameters affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry.
Scope of the Cancer Biopsy Market:
The Cancer Biopsy Market Research report incorporates value chain analysis for each of the product type. Value chain analysis offers in-depth information about value addition at each stage.The study includes drivers and restraints for Cancer Biopsy Market along with their impact on demand during the forecast period. The study also provides key market indicators affecting thegrowth of the market. Research report includes major key player analysis with shares of each player inside market, growth rate and market attractiveness in different endusers/regions. Our study Cancer Biopsy Market helps user to make precise decision in order to expand their market presence and increase market share.
By Type, Cancer Biopsy market has been segmented into:
Instruments
Kits and Consumables
and Services
By Application, Cancer Biopsy market has been segmented into:
((Tissue Biopsy (Needle Biopsy (Fine Needle Aspiration (FNA
Regional Analysis:
North America (U.S., Canada, Mexico)
Europe (Germany, U.K., France, Italy, Russia, Spain, Rest of Europe)
Asia-Pacific (China, India, Japan, Singapore, Australia, New Zealand, Rest of APAC)
South America (Brazil, Argentina, Rest of SA)
Middle East & Africa (Turkey, Saudi Arabia, Iran, UAE, Africa, Rest of MEA)
Competitive Landscape:
Competitive analysis is the study of strength and weakness, market investment, market share, market sales volume, market trends of major players in the market.The Cancer Biopsy market study focused on including all the primary level, secondary level and tertiary level competitors in the report. The data generated by conducting the primary and secondary research.The report covers detail analysis of driver, constraints and scope for new players entering the Cancer Biopsy market.
Top Key Players Covered in Cancer Biopsy market are:
QIAGEN
Illuminainc.
Angle PLC
Myriad Genetics
COUNSYLinc.
Hologicinc.
Bioceptinc.
Thermo Fisher Scientificinc.
Danaher
F. Hoffmann-La Roche Ltd.
Epigenomics AG
BD (Becton
Dickinson and Company)
Helio Health (Laboratory for Advanced Medicine)
among others.
Chapter 1: Introduction
1.1 Scope and Coverage
Chapter 2:Executive Summary
Chapter 3: Market Landscape
3.1 Market Dynamics
3.1.1 Drivers
3.1.2 Restraints
3.1.3 Opportunities
3.1.4 Challenges
3.2 Market Trend Analysis
3.3 PESTLE Analysis
3.4 Porter's Five Forces Analysis
3.5 Industry Value Chain Analysis
3.6 Ecosystem
3.7 Regulatory Landscape
3.8 Price Trend Analysis
3.9 Patent Analysis
3.10 Technology Evolution
3.11 Investment Pockets
3.12 Import-Export Analysis
Chapter 4: Cancer Biopsy Market by Type
4.1 Cancer Biopsy Market Snapshot and Growth Engine
4.2 Cancer Biopsy Market Overview
4.3 Instruments
4.3.1 Introduction and Market Overview
4.3.2 Historic and Forecasted Market Size in Value USD and Volume Units (2026-2035F)
4.3.3 Key Market Trends, Growth Factors and Opportunities
4.3.4 Instruments: Geographic Segmentation Analysis
4.4 Kits and Consumables
4.4.1 Introduction and Market Overview
4.4.2 Historic and Forecasted Market Size in Value USD and Volume Units (2026-2035F)
4.4.3 Key Market Trends, Growth Factors and Opportunities
4.4.4 Kits and Consumables: Geographic Segmentation Analysis
4.5 and Services
4.5.1 Introduction and Market Overview
4.5.2 Historic and Forecasted Market Size in Value USD and Volume Units (2026-2035F)
4.5.3 Key Market Trends, Growth Factors and Opportunities
4.5.4 and Services: Geographic Segmentation Analysis
Chapter 5: Cancer Biopsy Market by Application
5.1 Cancer Biopsy Market Snapshot and Growth Engine
5.2 Cancer Biopsy Market Overview
5.3 ((Tissue Biopsy (Needle Biopsy (Fine Needle Aspiration (FNA
5.3.1 Introduction and Market Overview
5.3.2 Historic and Forecasted Market Size in Value USD and Volume Units (2026-2035F)
5.3.3 Key Market Trends, Growth Factors and Opportunities
5.3.4 ((Tissue Biopsy (Needle Biopsy (Fine Needle Aspiration (FNA: Geographic Segmentation Analysis
Chapter 6: Company Profiles and Competitive Analysis
6.1 Competitive Landscape
6.1.1 Competitive Benchmarking
6.1.2 Cancer Biopsy Market Share by Manufacturer (2023)
6.1.3 Industry BCG Matrix
6.1.4 Heat Map Analysis
6.1.5 Mergers and Acquisitions
6.2 QIAGEN
6.2.1 Company Overview
6.2.2 Key Executives
6.2.3 Company Snapshot
6.2.4 Role of the Company in the Market
6.2.5 Sustainability and Social Responsibility
6.2.6 Operating Business Segments
6.2.7 Product Portfolio
6.2.8 Business Performance
6.2.9 Key Strategic Moves and Recent Developments
6.2.10 SWOT Analysis
6.3 ILLUMINAINC.
6.4 ANGLE PLC
6.5 MYRIAD GENETICS
6.6 COUNSYLINC.
6.7 HOLOGICINC.
6.8 BIOCEPTINC.
6.9 THERMO FISHER SCIENTIFICINC.
6.10 DANAHER
6.11 F. HOFFMANN-LA ROCHE LTD.
6.12 EPIGENOMICS AG
6.13 BD (BECTON
6.14 DICKINSON AND COMPANY)
6.15 AND HELIO HEALTH (LABORATORY FOR ADVANCED MEDICINE)
6.16 AMONG OTHERS.
Chapter 7: Global Cancer Biopsy Market By Region
7.1 Overview
7.2. North America Cancer Biopsy Market
7.2.1 Key Market Trends, Growth Factors and Opportunities
7.2.2 Top Key Companies
7.2.3 Historic and Forecasted Market Size by Segments
7.2.4 Historic and Forecasted Market Size By Type
7.2.4.1 Instruments
7.2.4.2 Kits and Consumables
7.2.4.3 and Services
7.2.5 Historic and Forecasted Market Size By Application
7.2.5.1 ((Tissue Biopsy (Needle Biopsy (Fine Needle Aspiration (FNA
7.2.6 Historic and Forecast Market Size by Country
7.2.6.1 US
7.2.6.2 Canada
7.2.6.3 Mexico
7.3. Eastern Europe Cancer Biopsy Market
7.3.1 Key Market Trends, Growth Factors and Opportunities
7.3.2 Top Key Companies
7.3.3 Historic and Forecasted Market Size by Segments
7.3.4 Historic and Forecasted Market Size By Type
7.3.4.1 Instruments
7.3.4.2 Kits and Consumables
7.3.4.3 and Services
7.3.5 Historic and Forecasted Market Size By Application
7.3.5.1 ((Tissue Biopsy (Needle Biopsy (Fine Needle Aspiration (FNA
7.3.6 Historic and Forecast Market Size by Country
7.3.6.1 Bulgaria
7.3.6.2 The Czech Republic
7.3.6.3 Hungary
7.3.6.4 Poland
7.3.6.5 Romania
7.3.6.6 Rest of Eastern Europe
7.4. Western Europe Cancer Biopsy Market
7.4.1 Key Market Trends, Growth Factors and Opportunities
7.4.2 Top Key Companies
7.4.3 Historic and Forecasted Market Size by Segments
7.4.4 Historic and Forecasted Market Size By Type
7.4.4.1 Instruments
7.4.4.2 Kits and Consumables
7.4.4.3 and Services
7.4.5 Historic and Forecasted Market Size By Application
7.4.5.1 ((Tissue Biopsy (Needle Biopsy (Fine Needle Aspiration (FNA
7.4.6 Historic and Forecast Market Size by Country
7.4.6.1 Germany
7.4.6.2 UK
7.4.6.3 France
7.4.6.4 Netherlands
7.4.6.5 Italy
7.4.6.6 Russia
7.4.6.7 Spain
7.4.6.8 Rest of Western Europe
7.5. Asia Pacific Cancer Biopsy Market
7.5.1 Key Market Trends, Growth Factors and Opportunities
7.5.2 Top Key Companies
7.5.3 Historic and Forecasted Market Size by Segments
7.5.4 Historic and Forecasted Market Size By Type
7.5.4.1 Instruments
7.5.4.2 Kits and Consumables
7.5.4.3 and Services
7.5.5 Historic and Forecasted Market Size By Application
7.5.5.1 ((Tissue Biopsy (Needle Biopsy (Fine Needle Aspiration (FNA
7.5.6 Historic and Forecast Market Size by Country
7.5.6.1 China
7.5.6.2 India
7.5.6.3 Japan
7.5.6.4 South Korea
7.5.6.5 Malaysia
7.5.6.6 Thailand
7.5.6.7 Vietnam
7.5.6.8 The Philippines
7.5.6.9 Australia
7.5.6.10 New Zealand
7.5.6.11 Rest of APAC
7.6. Middle East & Africa Cancer Biopsy Market
7.6.1 Key Market Trends, Growth Factors and Opportunities
7.6.2 Top Key Companies
7.6.3 Historic and Forecasted Market Size by Segments
7.6.4 Historic and Forecasted Market Size By Type
7.6.4.1 Instruments
7.6.4.2 Kits and Consumables
7.6.4.3 and Services
7.6.5 Historic and Forecasted Market Size By Application
7.6.5.1 ((Tissue Biopsy (Needle Biopsy (Fine Needle Aspiration (FNA
7.6.6 Historic and Forecast Market Size by Country
7.6.6.1 Turkey
7.6.6.2 Bahrain
7.6.6.3 Kuwait
7.6.6.4 Saudi Arabia
7.6.6.5 Qatar
7.6.6.6 UAE
7.6.6.7 Israel
7.6.6.8 South Africa
7.7. South America Cancer Biopsy Market
7.7.1 Key Market Trends, Growth Factors and Opportunities
7.7.2 Top Key Companies
7.7.3 Historic and Forecasted Market Size by Segments
7.7.4 Historic and Forecasted Market Size By Type
7.7.4.1 Instruments
7.7.4.2 Kits and Consumables
7.7.4.3 and Services
7.7.5 Historic and Forecasted Market Size By Application
7.7.5.1 ((Tissue Biopsy (Needle Biopsy (Fine Needle Aspiration (FNA
7.7.6 Historic and Forecast Market Size by Country
7.7.6.1 Brazil
7.7.6.2 Argentina
7.7.6.3 Rest of SA
Chapter 8 Analyst Viewpoint and Conclusion
8.1 Recommendations and Concluding Analysis
8.2 Potential Market Strategies
Chapter 9 Research Methodology
9.1 Research Process
9.2 Primary Research
9.3 Secondary Research
Cancer Biopsy Scope:
|
Report Data
|
Cancer Biopsy Market
|
|
Cancer Biopsy Market Size in 2025
|
USD XX million
|
|
Cancer Biopsy CAGR 2025 - 2032
|
XX%
|
|
Cancer Biopsy Base Year
|
2024
|
|
Cancer Biopsy Forecast Data
|
2025 - 2032
|
|
Segments Covered
|
By Type, By Application, And by Regions
|
|
Regional Scope
|
North America, Europe, Asia Pacific, Latin America, and Middle East & Africa
|
|
Key Companies Profiled
|
QIAGEN, Illuminainc., Angle PLC, Myriad Genetics, COUNSYLinc., Hologicinc., Bioceptinc., Thermo Fisher Scientificinc., Danaher, F. Hoffmann-La Roche Ltd., Epigenomics AG, BD (Becton, Dickinson and Company), and Helio Health (Laboratory for Advanced Medicine), among others..
|
|
Key Segments
|
By Type
Instruments
Kits and Consumables
and Services
By Applications
((Tissue Biopsy (Needle Biopsy (Fine Needle Aspiration (FNA
|
